US Patent Issued to Emory University, Children's Healthcare of Atlanta on Feb. 10 for "Chimeric RSV and HMPV F proteins, immunogenic compositions, and methods of use" (California, Georgia, Indiana Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,436, issued on Feb. 10, was assigned to Emory University (Atlanta) and Children's Healthcare of Atlanta Inc. (Atlanta).

"Chimeric RSV and HMPV F proteins, immunogenic compositions, and methods of use" was invented by Martin L. Moore (South San Francisco, Calif.), Sean Todd (Atlanta) and Christopher C. Stobart (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes a chimeric respiratory syncytial virus encoding a chimeric RSV and hMPV F protein and uses of the chimeric virus or components therein in a vaccine. In certain embodiments, this disclosure describes a live attenuated vaccine comprising an RSV backbone substit...